Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
My69z's Profile
Displaying 851-900 of 1168 result(s).
CYDY CytoDyn Inc
07/24/2024 10:23:15 AM
Dam good 1st read-out results. (2)
CYDY CytoDyn Inc
07/24/2024 1:15:03 AM
Detailed AAV info --- https://www.n (1)
CYDY CytoDyn Inc
07/24/2024 12:48:14 AM
& LL goes into muscle tissue ---- h (3)
CYDY CytoDyn Inc
07/24/2024 12:30:40 AM
Agree 100%. Anything FDA approves a (1)
CYDY CytoDyn Inc
07/24/2024 12:13:24 AM
& continued AAV work is funded. htt (3)
CYDY CytoDyn Inc
07/23/2024 1:15:24 PM
& Plotinus, Maraviroc -- how about (5)
CYDY CytoDyn Inc
07/23/2024 9:53:46 AM
Nice!! & Dr. Sacha is funded to 202 (5)
CYDY CytoDyn Inc
07/22/2024 11:16:23 PM
Also Maraviroc and BMS-813160: BMS- (6)
CYDY CytoDyn Inc
07/22/2024 10:59:38 PM
& the "safety" of the drugs: Cetuxi (7)
CYDY CytoDyn Inc
07/22/2024 9:41:21 AM
https://stocktwits.com/Fredsavage9 (6)
CYDY CytoDyn Inc
07/20/2024 5:47:39 PM
Man..what tha?!?!!...haha. U rgt
CYDY CytoDyn Inc
07/20/2024 5:44:17 PM
So from syringe, to body producing (3)
CYDY CytoDyn Inc
07/20/2024 2:12:58 PM
It's not funded or in direct collab
CYDY CytoDyn Inc
07/20/2024 1:05:06 PM
Monkeys have beat the mice for 1st
CYDY CytoDyn Inc
07/20/2024 12:53:42 PM
Nope. No mention. Most likely becau (3)
CYDY CytoDyn Inc
07/20/2024 10:02:32 AM
for Influenza.
CYDY CytoDyn Inc
07/20/2024 10:01:39 AM
2007 Cytodyn kicked around DNA vacc (1)
CYDY CytoDyn Inc
07/20/2024 2:26:46 AM
LL verifiably current/for testing: (15)
CYDY CytoDyn Inc
07/20/2024 1:29:06 AM
LL's going to be one stop-shop for (7)
CYDY CytoDyn Inc
07/20/2024 1:15:35 AM
Award Notice Date 02-July-2024: "To (10)
CYDY CytoDyn Inc
07/20/2024 12:50:35 AM
WOW!!...Project End Date 30-June-20 (13)
CYDY CytoDyn Inc
07/17/2024 6:02:55 AM
To clarify the optimal dosing and e (2)
CYDY CytoDyn Inc
07/16/2024 9:26:50 PM
Thursday is 4 of the MASH 12 weeks. (1)
CYDY CytoDyn Inc
07/12/2024 10:41:52 PM
Right.
CYDY CytoDyn Inc
07/12/2024 4:32:44 PM
Oct 07, 2021 with $16.5m in the kit (1)
CYDY CytoDyn Inc
07/10/2024 7:40:33 PM
On warrants closing = Masterclass.
CYDY CytoDyn Inc
07/10/2024 12:51:16 AM
" I don't think an arbitrator would (21)
CYDY CytoDyn Inc
07/09/2024 10:19:51 PM
I meant, if they motion & win monet (1)
CYDY CytoDyn Inc
07/09/2024 10:09:45 PM
What about DOJ releasing their judg (1)
CYDY CytoDyn Inc
07/09/2024 12:52:17 PM
$10m -- public schooling strikes ag (2)
CYDY CytoDyn Inc
07/09/2024 12:47:33 PM
Take say $50m -- a 20% down payment (11)
CYDY CytoDyn Inc
07/09/2024 9:27:03 AM
The image & book value this adds; w (12)
CYDY CytoDyn Inc
07/07/2024 3:01:42 AM
7/23 Leqembi for Alzheimers: The co (2)
CYDY CytoDyn Inc
07/07/2024 1:12:24 AM
" The 350-mg dose of leronlimab sig (1)
CYDY CytoDyn Inc
07/07/2024 12:03:53 AM
6/22 -- 14 week NASH Patients EASL (4)
CYDY CytoDyn Inc
07/04/2024 2:57:37 AM
(1) Keytruda (pembrolizumab) can ca (10)
CYDY CytoDyn Inc
07/04/2024 2:15:00 AM
I agree, it's like --- don't piss d (7)
CYDY CytoDyn Inc
07/03/2024 2:08:55 PM
Semaglutide, the active ingredient (4)
CYDY CytoDyn Inc
07/01/2024 12:35:58 PM
NIH -- mentioned too many times by (3)
CYDY CytoDyn Inc
07/01/2024 12:14:06 PM
I kinda hit on that & throw in Cyto (1)
CYDY CytoDyn Inc
06/30/2024 1:29:10 PM
ohm & MG -- thx to you 2, now im ev (1)
CYDY CytoDyn Inc
06/30/2024 1:11:35 AM
ohm20, sounds like it's LL 350mg @ (1)
CYDY CytoDyn Inc
06/29/2024 5:23:34 PM
Lol.... (2)
CYDY CytoDyn Inc
06/29/2024 10:00:50 AM
A 15 cent stock, going after a $280 (1)
CYDY CytoDyn Inc
06/29/2024 8:48:29 AM
Proof investing can "age" you....iy (1)
CYDY CytoDyn Inc
06/28/2024 8:24:43 PM
Dam it -- 4got the link: https://ww (2)
CYDY CytoDyn Inc
06/28/2024 8:24:09 PM
A separate LL arm was going to be p
CYDY CytoDyn Inc
06/28/2024 12:11:20 PM
Good reply Plotinus.
CYDY CytoDyn Inc
06/27/2024 7:55:01 PM
Resmetirom daily dose 80-100mg. We' (8)
CYDY CytoDyn Inc
06/27/2024 7:39:37 PM
Plotinus -- WebMd Interaction Track (1)
Go to page:
  • << First
  • < Previous
  • 17
  • 18
  • Next >

Recent Articles

  • Healthcare System Expands Digital Pathology with Sectra Cloud
  • Beko Emerges as a Leader in Global Sustainability Rankings
  • Capture Every Moment with the Innovative AKASO 360 Camera
  • Beko Ranked Top Among Sustainable Companies, Leading the Way
  • Enhancing Ad Effectiveness with Productsup's Latest CSS Service
  • Divergence: Understanding Global Currency Movements Amid Stock Surge
  • Nykredit A/S Announces Latest Prepayment Data Insights
  • Latest Prepayment Insights from Totalkredit A/S for Investors
  • Skanska Initiates Construction on Next-Gen Sports Complex
  • Unlocking Europe's Potential: Biosolutions Driving Economic Growth
  • Microsoft's Layoffs Spark Controversy Over AI Support
  • Understanding Your Rights as a WST Shareholder: Key Insights
  • Skanska Announces New Multi-Sports Facility in Malmö
  • Skanska's Ambitious Long Bridge North Project Boosts Connectivity
  • iGarden Pool Cleaner K Pro 150: The Future of Pool Maintenance
  • Skanska Enters Major Contract for Long Bridge North Project
  • Class Action Lawsuit Update for Digimarc Corporation Investors
  • Sterling Trading Tech Honored for Excellence in Trading Solutions
  • Lightchain AI Advances with Developer Grants and Bonus Round Launch
  • Insights into Jyske Bank's Share Repurchase Programme
  • Ellomay Capital Partners with Statkraft for Solar Energy Expansion
  • Upcoming Outlook on Shell's Financial Performance and Strategy
  • Ontex Group Announces Major Shareholding Change Details
  • Elis Reports Own Shares Trading Activity and Future Plans
  • OSB Group PLC Launches Share Buyback for Growth Strategy
  • Foresight Group Holdings' Ongoing Share Buyback Program Update
  • Latest Insights on NBPE's Share Buyback and Market Position
  • Revolutionizing Payments: Mastercard's New Biometric Metal Card
  • Global Digital Economy Collaboration Forum Launches Strategic Ventures
  • Vast Resources plc Announces Employee Share Scheme Awards
  • Skanska Expands Presence with New 14-Year Office Lease Agreement
  • Revamped Spaces at Vilnius Akropolis Enhance Visitor Experience
  • Shell PLC Updates with Q2 2025 Financial Outlook Insights
  • Ontex Group NV Announces Significant Shareholding Update
  • Mastercard Unveils Innovative Biometric Metal Card in Bangladesh
  • Elis' Recent Share Trading: Key Insights and Highlights
  • TikTok Readies New App for U.S. Users Amid Sale Talks
  • Skanska Secures Long-Term Lease for Iconic Office Space
  • TECNO POVA 7 Series Celebrates Success with Awards
  • NetDragon Recognized for Innovation in Education Technology
  • ONWARD Medical Welcomes Tim Denison to its Board Team
  • Exciting Additions to ONWARD Medical's Leadership Team
  • Cathie Wood's Insights on Bitcoin Movements and Government Actions
  • KONE Egypt Unveils Innovative Training Center for Urban Growth
  • Capgemini's Strategic Acquisition of WNS to Elevate AI Operations
  • Elon Musk's America Party: A New Era for Bitcoin Enthusiasts
  • Elon Musk Challenges FEC Filing for New Political Party
  • Empowering Sustainable Operations: Indosat Ooredoo & Nokia Unite
  • Capgemini's Strategic Acquisition of WNS for Intelligent Operations
  • U by Emaar Expands Loyalty Program with Address Istanbul
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site